NCT05896943Completed
The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab
The Application of Transcriptomics for Establishing Potential Prognostic Markers of Response to Treatment of Ulcerative Colitis With Ustekinumab
Source: ClinicalTrials.gov · Last updated 12 Mar 2025
Brief summary (registry, in English)
The investigators hope that the present study will highlight new transcriptomic prognostic markers of response to Ustekinumab with the ultimate goal of individualizing treatment and making a more targeted selection of UC patients who will benefit from this biological agent.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 38 (actual)
- First submitted
- 8 May 2023
- Start date
- 1 Apr 2022
- Primary completion date
- 31 Oct 2023
- Lead sponsor
- Evangelismos Hospital
- Diseases
- Ulcerative colitis
- NCT number
- NCT05896943
What you commit to
- Study type: Observational
- Participants enrolled: 38
- From 1 Apr 2022 to the primary completion date, 31 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior surgical history for UC
- Patients who received any approved biologic agent (e.g. Infliximab, adalimumab, vedolizumab, golimumab) within the previous 8 weeks or any investigational biologic or other agent in the last 35 days
Other illness
- Infectious complications (Cl. Difficile, CMV infection)
Other
- Toxic megacolon
Who the study is looking for
- Active UC in accordance with applicable diagnostic criteria \[25\] •
- Aged 18 or above
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Evangelismos Hospital Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.